<i>CRLF2</i> -rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapySara Silbert, Nirali N. Shah, Sandra D. Bohling et al.|Journal for ImmunoTherapy of Cancer|2024Cited by 8
1631P Results from the quick efficacy seeking trial (QuEST1) arm combining BN-brachyury (BNVax) + bintrafusp alfa (BA) + nogapendekin alfa inbakicept-pmln (N-803) in castration-resistant prostate cancer (CRPC)Jason M. Redman, James L. Gulley, Ravi A. Madan et al.|Annals of Oncology|2024Cited by 3
Complete Response in Hairy Cell Leukemia to Anti-CD22 CAR T-Cell TherapyRobert J. Kreitman, Nirali N. Shah, Brett Schroeder et al.|JCO Precision Oncology|2025Cited by 2
Abstract 12350: Detection of Preclinical Hypertrophic Cardiomyopathy Mutations With Advanced Imaging: The Hypertrophic Cardiomyopathy Network (HCMNet) StudyEunice Yang, David A. Bluemke, Songtao Liu et al.|Circulation|2013Cited by 0
Prospective Study Utilizing PET-CT and Next-Generation Sequencing to Evaluate for Peri-CAR T-Cell Non-CNS Extramedullary Disease in B-Acute Lymphoblastic LeukemiaBrynn B. Duncan, Nirali N. Shah, Alexander W. Rankin et al.|Transplantation and Cellular Therapy|2025Cited by 0